Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Tamra, Slone"'
Autor:
Anupam Verma, Yueh-Yun Chi, Jemily Malvar, Adam Lamble, Sonali Chaudhury, Archana Agarwal, Hong-Tao Li, Gangning Liang, Roy Leong, Patrick A. Brown, Joel Kaplan, Eric S. Schafer, Tamra Slone, Melinda Pauly, Bill H. Chang, Elliot Stieglitz, Alan S. Wayne, Nobuko Hijiya, Deepa Bhojwani
Publikováno v:
Cancers, Vol 16, Iss 3, p 496 (2024)
Improvements in survival have been made over the past two decades for childhood acute myeloid leukemia (AML), but the approximately 40% of patients who relapse continue to have poor outcomes. A combination of checkpoint-inhibitor nivolumab and azacit
Externí odkaz:
https://doaj.org/article/498c6ca081b64cb09353822d5f07e337
Autor:
Sarai H. Stuart, Veena Rajaram, Kenneth S. Chen, James F. Amatruda, Emily K. Stroup, Gordan M. Vujanic, Tamra Slone, Dinesh Rakheja, Abhay S. Shukla, Jason Wang
Publikováno v:
JCO Precision Oncology. :1-9
DICER1 syndrome1 predisposes to a variety of cancers, including pleuropulmonary blastoma (PPB),2 ovarian Sertoli-Leydig cell tumor (SLCT),3 embryonal rhabdomyosarcoma,4 and kidney tumors.5–8 In DICER1 syndrome, most patients bear a germline null mu
The risk of the novel coronavirus disease 2019 (COVID-19) to pediatric oncology patients is unknown. Here, we report eight pediatric oncology patients receiving active cancer therapy that tested positive for COVID-19. Three developed severe cardiores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31d3fedf8d918315b5b84fffd73341c5
https://doi.org/10.22541/au.161670421.11574183/v1
https://doi.org/10.22541/au.161670421.11574183/v1
Autor:
Tamra Slone, Linda Zimmerman, E. Anders Kolb, Jennifer Poon, Keith J. August, Mathew Simcock, Noha Biserna, Maureen M. O'Brien, Meera Patturajan, Nianhang Chen, John E. Levine, Patrick A. Brown, Todd Cooper, Todd A. Alonzo, Bouchra Benettaib
Publikováno v:
Pediatric Blood & Cancer. 68
Background Outcomes after relapse remain poor in pediatric patients with acute myeloid leukemia (AML), and new therapeutic approaches are needed. Lenalidomide has demonstrated activity in adults with lower risk myelodysplastic syndromes and older adu
Autor:
Kenneth S, Chen, Sarai H, Stuart, Emily K, Stroup, Abhay S, Shukla, Jason, Wang, Veena, Rajaram, Gordan M, Vujanic, Tamra, Slone, Dinesh, Rakheja, James F, Amatruda
Publikováno v:
JCO precision oncology. 2
Autor:
Paul K. Sue, Maria Bisceglia, Tamra Slone, Victor M. Aquino, Esra Akkoyun, Jesus Sotelo, Giselle Cherry
Publikováno v:
Blood
Background Outcomes of COVID-19 infection among children with underlying malignancy remain unclear, with limited data available to date. Here we report clinical characteristics and outcomes following COVID-19 infection among children with underlying
Autor:
Weina Chen, James F. Amatruda, Jingjing Xie, Jinhui Shen, Lily Jun Shen Huang, Min Luo, Cheng Cheng Zhang, Naomi J. Winick, Zhigang Lu, Philipp E. Scherer, Yizhou Zou, Guojin Wu, Robert H. Collins, Xunlei Kang, Tamra Slone
Publikováno v:
Nature Medicine. 23:79-90
New therapeutic approaches are needed to treat leukemia effectively. Dietary restriction regimens, including fasting, have been considered for the prevention and treatment of certain solid tumor types. However, whether and how dietary restriction aff
Autor:
Erica I. Hodgman, Rachel Renkes, Adam C. Alder, Lorraine S. Burkhalter, Tamra Slone, Aurelia B. Fu
Publikováno v:
Journal of Surgical Research. 205:419-425
Background Central venous access devices (CVADs) play an important role in the management of pediatric oncology patients; unfortunately, they are also associated with potentially serious complication rates. We hypothesized that, despite the significa
Publikováno v:
Open Forum Infectious Diseases
Background Bacteremia is a major cause of morbidity and mortality among children with acute myelogenous leukemia (AML) and chemotherapy-induced neutropenia. Data evaluating the utility of bacterial prophylaxis in this pediatric population are limited
Autor:
Victor M. Aquino, Kimberly Donner, Paul K. Sue, Naomi J. Winick, Gopi B. Shah, Tamra Slone, Gohar Warraich
Publikováno v:
Open Forum Infectious Diseases
Background Invasive fungal sinusitis (IFS) is a cause of significant morbidity and mortality among children with hematologic malignancy and hematopoietic stem cell transplant (HSCT) recipients, with an estimated mortality of 18–80%. Since 2007, our